These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Conserved signaling pathways underlying heterotopic ossification. Kan C; Chen L; Hu Y; Ding N; Lu H; Li Y; Kessler JA; Kan L Bone; 2018 Apr; 109():43-48. PubMed ID: 28455214 [TBL] [Abstract][Full Text] [Related]
7. BMP-dependent, injury-induced stem cell niche as a mechanism of heterotopic ossification. Kan C; Ding N; Yang J; Tan Z; McGuire TL; Lu H; Zhang K; Berger DMP; Kessler JA; Kan L Stem Cell Res Ther; 2019 Jan; 10(1):14. PubMed ID: 30635039 [TBL] [Abstract][Full Text] [Related]
8. The obligatory role of Activin A in the formation of heterotopic bone in Fibrodysplasia Ossificans Progressiva. Alessi Wolken DM; Idone V; Hatsell SJ; Yu PB; Economides AN Bone; 2018 Apr; 109():210-217. PubMed ID: 28629737 [TBL] [Abstract][Full Text] [Related]
9. Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesis. Ahn J; Serrano de la Pena L; Shore EM; Kaplan FS J Bone Joint Surg Am; 2003 Apr; 85(4):667-74. PubMed ID: 12672843 [TBL] [Abstract][Full Text] [Related]
10. Transgenic mice overexpressing BMP4 develop a fibrodysplasia ossificans progressiva (FOP)-like phenotype. Kan L; Hu M; Gomes WA; Kessler JA Am J Pathol; 2004 Oct; 165(4):1107-15. PubMed ID: 15466378 [TBL] [Abstract][Full Text] [Related]
11. Identification of progenitor cells that contribute to heterotopic skeletogenesis. Lounev VY; Ramachandran R; Wosczyna MN; Yamamoto M; Maidment AD; Shore EM; Glaser DL; Goldhamer DJ; Kaplan FS J Bone Joint Surg Am; 2009 Mar; 91(3):652-63. PubMed ID: 19255227 [TBL] [Abstract][Full Text] [Related]
12. In vivo somatic cell gene transfer of an engineered Noggin mutein prevents BMP4-induced heterotopic ossification. Glaser DL; Economides AN; Wang L; Liu X; Kimble RD; Fandl JP; Wilson JM; Stahl N; Kaplan FS; Shore EM J Bone Joint Surg Am; 2003 Dec; 85(12):2332-42. PubMed ID: 14668502 [TBL] [Abstract][Full Text] [Related]
13. Cellular Hypoxia Promotes Heterotopic Ossification by Amplifying BMP Signaling. Wang H; Lindborg C; Lounev V; Kim JH; McCarrick-Walmsley R; Xu M; Mangiavini L; Groppe JC; Shore EM; Schipani E; Kaplan FS; Pignolo RJ J Bone Miner Res; 2016 Sep; 31(9):1652-65. PubMed ID: 27027798 [TBL] [Abstract][Full Text] [Related]
14. Spatial patterns of heterotopic ossification in fibrodysplasia ossificans progressiva correlate with anatomic temperature gradients. Wang H; De Cunto CL; Pignolo RJ; Kaplan FS Bone; 2021 Aug; 149():115978. PubMed ID: 33915334 [TBL] [Abstract][Full Text] [Related]
16. Early clinical observations on the use of imatinib mesylate in FOP: A report of seven cases. Kaplan FS; Andolina JR; Adamson PC; Teachey DT; Finklestein JZ; Ebb DH; Whitehead B; Jacobs B; Siegel DM; Keen R; Hsiao E; Pignolo RJ Bone; 2018 Apr; 109():276-280. PubMed ID: 28736245 [TBL] [Abstract][Full Text] [Related]
17. [Fibrodysplasia ossificans progressiva and osteoimmunology]. Katagiri T Clin Calcium; 2016 May; 26(5):691-8. PubMed ID: 27117614 [TBL] [Abstract][Full Text] [Related]
18. Retinoid roles and action in skeletal development and growth provide the rationale for an ongoing heterotopic ossification prevention trial. Pacifici M Bone; 2018 Apr; 109():267-275. PubMed ID: 28826842 [TBL] [Abstract][Full Text] [Related]
19. Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP). Fiori JL; Billings PC; de la Peña LS; Kaplan FS; Shore EM J Bone Miner Res; 2006 Jun; 21(6):902-9. PubMed ID: 16753021 [TBL] [Abstract][Full Text] [Related]